BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 29204893)

  • 1. The Development of a Patient-Reported Outcome Measure for Assessment of Genital Psoriasis Symptoms: The Genital Psoriasis Symptoms Scale (GPSS).
    Gottlieb AB; Kirby B; Ryan C; Naegeli AN; Burge R; Potts Bleakman A; Anatchkova MD; Yosipovitch G
    Dermatol Ther (Heidelb); 2018 Mar; 8(1):45-56. PubMed ID: 29204893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Development of the Genital Psoriasis Sexual Frequency Questionnaire (GenPs-SFQ) to Assess the Impact of Genital Psoriasis on Sexual Health.
    Gottlieb AB; Kirby B; Ryan C; Naegeli AN; Burge R; Potts Bleakman A; Anatchkova MD; Cather J
    Dermatol Ther (Heidelb); 2018 Mar; 8(1):33-44. PubMed ID: 29204894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ixekizumab Improved Patient-Reported Genital Psoriasis Symptoms and Impact of Symptoms on Sexual Activity vs Placebo in a Randomized, Double-Blind Study.
    Yosipovitch G; Foley P; Ryan C; Cather JC; Meeuwis KA; Burge R; Bleakman AP; Lin CY; Malatestinic W; Gottlieb A
    J Sex Med; 2018 Nov; 15(11):1645-1652. PubMed ID: 30415816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patients' Perspectives on the Impact of Genital Psoriasis: A Qualitative Study.
    Cather JC; Ryan C; Meeuwis K; Potts Bleakman AJ; Naegeli AN; Edson-Heredia E; Poon JL; Jones C; Wallace AN; Guenther L; Fretzin S
    Dermatol Ther (Heidelb); 2017 Dec; 7(4):447-461. PubMed ID: 29076000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ixekizumab improves secondary lesional signs, pain and sexual health in patients with moderate-to-severe genital psoriasis.
    Merola JF; Ghislain PD; Dauendorffer JN; Potts Bleakman A; Brnabic AJM; Burge R; Riedl E
    J Eur Acad Dermatol Venereol; 2020 Jun; 34(6):1257-1262. PubMed ID: 31919919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of genital psoriasis in patients with psoriasis.
    Meeuwis KAP; Potts Bleakman A; van de Kerkhof PCM; Dutronc Y; Henneges C; Kornberg LJ; Menter A
    J Dermatolog Treat; 2018 Dec; 29(8):754-760. PubMed ID: 29565190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of ixekizumab in a randomized, double-blinded, placebo-controlled phase IIIb study of patients with moderate-to-severe genital psoriasis.
    Ryan C; Menter A; Guenther L; Blauvelt A; Bissonnette R; Meeuwis K; Sullivan J; Cather JC; Yosipovitch G; Gottlieb AB; Merola JF; Callis Duffin K; Fretzin S; Osuntokun OO; Burge R; Naegeli AN; Yang FE; Lin CY; Todd K; Potts Bleakman A;
    Br J Dermatol; 2018 Oct; 179(4):844-852. PubMed ID: 29747232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Symptom Experience and Content Validity of the Psoriasis Symptom Scale (PSS) in Patients with Generalized Pustular Psoriasis (GPP).
    Burden AD; Mrowietz U; Skalicky AM; Rentz AM; Esser D; Gloede T; Thoma C; Menter A
    Dermatol Ther (Heidelb); 2022 Jun; 12(6):1367-1381. PubMed ID: 35590037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early development and qualitative evidence of content validity for the Psoriasis Symptom Inventory (PSI), a patient-reported outcome measure of psoriasis symptom severity.
    Martin ML; McCarrier KP; Chiou CF; Gordon K; Kimball AB; Van Voorhees AS; Gottlieb AB; Huang X; Globe D; Chau D; Viswanathan HN; Kricorian G
    J Dermatolog Treat; 2013 Aug; 24(4):255-60. PubMed ID: 23249143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological therapy in genital psoriasis in women.
    Burlando M; Herzum A; Carmisciano L; Cozzani E; Parodi A
    Dermatol Ther; 2020 Jan; 33(1):e13110. PubMed ID: 31595647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and Content Validation of the Psoriasis Symptoms and Impacts Measure (P-SIM) for Assessment of Plaque Psoriasis.
    Gottlieb AB; Ciaravino V; Cioffi C; Peterson L; Warren RB
    Dermatol Ther (Heidelb); 2020 Dec; 10(6):1255-1272. PubMed ID: 32844372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychometric properties of the Itch Numeric Rating Scale in patients with moderate-to-severe plaque psoriasis.
    Kimball AB; Naegeli AN; Edson-Heredia E; Lin CY; Gaich C; Nikaï E; Wyrwich K; Yosipovitch G
    Br J Dermatol; 2016 Jul; 175(1):157-62. PubMed ID: 26852717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The experience of itch in children with psoriasis: A qualitative exploration of the Itch Numeric Rating Scale.
    Mannix S; Edson-Heredia E; Paller AS; Yosipovitch G; Burge R; Kleinman L
    Pediatr Dermatol; 2021 Mar; 38(2):405-412. PubMed ID: 33336430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of the Psoriasis Symptoms Scale (PSS) in patients with moderate-to-severe psoriasis: qualitative and quantitative analyses.
    Armstrong AW; Edson-Heredia E; Naegeli AN; Burge R; Poon JL; Anatchkova M; Sun L; Zhu B; Wyrwich KW
    J Dermatolog Treat; 2020 Aug; 31(5):452-459. PubMed ID: 31157576
    [No Abstract]   [Full Text] [Related]  

  • 15. The Worst Itch Numeric Rating Scale for patients with moderate to severe plaque psoriasis or psoriatic arthritis.
    Naegeli AN; Flood E; Tucker J; Devlen J; Edson-Heredia E
    Int J Dermatol; 2015 Jun; 54(6):715-22. PubMed ID: 25515935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The content validity of the PSS in patients with plaque psoriasis.
    Rentz AM; Skalicky AM; Burslem K; Becker K; Kaschinski D; Esser D; Revicki DA
    J Patient Rep Outcomes; 2017; 1(1):4. PubMed ID: 29757301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring content and psychometric validity of newly developed assessment tools for itch and skin pain in atopic dermatitis.
    Newton L; DeLozier AM; Griffiths PC; Hill JN; Hudgens S; Symonds T; Gable JC; Paik J; Wyrwich KW; Eichenfield LF; Abetz-Webb L; Silverberg JI
    J Patient Rep Outcomes; 2019 Jul; 3(1):42. PubMed ID: 31312940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Psoriasis Symptom Diary: development and content validity of a novel patient-reported outcome instrument.
    Lebwohl M; Swensen AR; Nyirady J; Kim E; Gwaltney CJ; Strober BE
    Int J Dermatol; 2014 Jun; 53(6):714-22. PubMed ID: 23557000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of the Psoriasis Symptom Inventory (PSI), a patient-reported outcome measure to assess psoriasis symptom severity.
    Bushnell DM; Martin ML; McCarrier K; Gordon K; Chiou CF; Huang X; Ortmeier B; Kricorian G
    J Dermatolog Treat; 2013 Oct; 24(5):356-60. PubMed ID: 23092173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Qualitative analysis and reproducibility assessment of the Scalp Itch Numeric Rating Scale among patients with moderate to severe plaque psoriasis of the scalp.
    Wang Y; Coyne K; Sofen H; Santanello N; Currie B; Zhang Z; Nograles K
    J Dermatolog Treat; 2019 Dec; 30(8):775-783. PubMed ID: 30747550
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.